THEY WERE THERE

Participants & companies

TETRA PAK; MONDELEZ INTERNATIONAL; TNO-Pays Bas; NESTLÉ; DANONE; KRYSPY KERNELS; ITPSA; BIOVITA; DSM NUTRITIONAL ; NATURENVIE; SKJODT-BARRETT FOODS; QUADRA INGREDIENTS; CINTECH AGROALIMENTAIRE; AGROPUR; ASSOCIATION CANADIENNE DES PRODUITS NATURELS; PRO MEXICO; NATURAL PRODUCTS CANADA; GROUPE CLUSTER WAGRALIM; AG BIO CENTRE; SILICYCLE INC; EXTENSE PHARMA; BIOVELIA; LÉO DÉSILET/FACOTEK; CELABOR; PHARMAFRICANE; AMAZSTEV LIFESTLE BRANDS INC; PRODIGEST; YU LIFE;ABBOTT NUTRITION; DSM NUTRITIONAL; ACTUALITÉ ALIMENTAIRE/EDIKOM; SYNTBIOLAB; BIOK +; ATRIUM INNOVATIONS (GENESTRA & DOUGLAS LABORATORIES; BIOFOR-EXTRA;  PHARMA NATURE; DIANA FOODS ; ALIGO;VIT'ALL+; FEDÉRATION DES PRODUCTEURS ACERICOLES DU QUEBEC; BIOCÉAN; VALBIOTIS; GENOME QUEBEC; FRUIT D'OR; BIOFORTIS; CINTECH AGROALIMENATAIRE; KHLOROS; LABORATOIRES CLÉMASCIENCE; KSA AVOCATS; NUTRACANADA; ACTIV'INSIDE; LASSONDE; NUTRINOR; GROUPE PHARMANAGER; IDC DERMOCORRECTION;  ERGOGENIC; LESIEUR - GROUPE AVRIL; PHARMA LAB; KEFI PLANT; FSI; PHARMANAGER; ABBOTT NUTRITION; NUTRIKEO / CULTURE NUTRITION; PRODUCTEURS LAITIERS DU CANADA; GESTION SOVAR; BOTANIC CERT; LALLEMAND HEALTH SOLUTIONS; STENO DIABETES CENTER, DANEMARK; PRO CIRCUIT HIGH TECH NUTRITION; ENVIRONEX; INNOVACTIV; ALIMENT TRIGONE; 3M CANADA; PRO-AMINO INTERNATIONAL; PACHEM DISTRIBUTION; NUTRISIMPLE ;

Organizations-international delegations- services

VILLE DE QUÉBEC; QUÉBEC INTERNATIONAL; CRÉNEAU ALIMENTS SANTÉ; CRÉNEAU AGROBORÉAL; CRÉNEAU TRANSFORMACTION; CRÉNEAU RSTM; MAPAQ; AGRICULTURE CANADA; AISA - ASSOCIATION POUR LES INGRÉDIENTS SANTÉ EN ALIMENTATION; AQIA - ASSOCIATION QUÉBÉCOISE POUR L'INNOCUITÉ ALIMENTAIRE; ASQ-ALLIANCE SANTÉ QUEBEC; FONDACTION : CENTRE DE  RECHERCHE EN BIOTHECHNOLOGIE MARINE; CIATEJ -GUADALAJARA; CLUSTER AINS - INNOVATIVE BUSINESS ASSOCIATION ; NUTRITION-HEALTH; CTNS - THE TECHNOLOGICAL CENTRE OF NUTRITION AND HEALTH; PEI BIO ALLIANCE; REPRÉSENTATION DE L'ÉTAT DE BAVIÈRE AU QUÉBEC; REASEAU EURECAT/CTNS; INSPQ; GROUPE POLE DE COMPÉTITIVITÉ VITAGORA; CRSNG; POLE DE COMPETITIVITÉ FRANCAIS- NUTRITION SANTÉ LONGÉVITÉ; MITACS; CRIBIQ; CTAC - CONSEIL DE LA TRANSFORMATION ALIMENTAIRE DU QUEBEC; SANTÉ CANADA; PARI-CNRC; NATIONAL RESEARCH COUNCIL, ITALIE; MERINOV; TRANSBIOTECH

 

Canadian and international universities

UNIVERSITÉ LAVAL ; INAF- INSTITUT SUR LA NUTRITION ET ALIMENTS FONCTIONNELS, NUTRINEURO, INRA, BORDEAUX; UNIVERSITÉ DE BAYREUTH, ALLEMAGNE; DEAKIN UNIVERSITY, AUSTRALIA; WOMEN'S GLOBAL HEALTH INSTITUTE, PURDUE UNIVERSITY, IN, USA; BAYLOR COLLEGE OF MEDICINE, TX, USA; STENO DIABETES CENTER, DANEMARK; UNIVERSITY OF SOUTHAMPTON; DEPT PHARMACY & BIOTECHNOLOGY, BOLOGNA UNIVERSITY; DEPARTMENT OF PEDIATRICS, UNIVERSITY HOSPITAL OF COPENHAGEN; UNIVERSITY OF MANITOBA; UNIVERSITE DE LYON And many more!

SESSION CHAIRMEN

SESSION 1 – Cardiometabolic Diseases

Dr. Benoît Lamarche
• Professor, INAF, Université Laval, Canada

After having completed his undergraduate training in biochemistry, Dr. Benoît Lamarche graduated with a Ph.D. in Physiology at Laval University and completed a postdoctoral fellowship at the University of Toronto Faculty of Medicine. He is currently a full professor at the Department of Food Sciences and Nutrition at Laval University. Dr. Lamarche’s research includes biomedical, clinical and epidemiological studies of the impact of diet and nutrition on cardio-metabolic risk factors associated with obesity and metabolic syndrome. Most recently, he studied the impact of dairy trans fatty acids on the risks associated with metabolic syndrome. His research has led to numerous collaborations with renowned researchers around the world. He has published more than 200 articles in international scientific journals and has received several awards over the course of his career.

Marie-Caroline Michalski

Dr. Marie-Caroline Michalski
• Université Lyon 1, France

Metabolic Impact of fat Emulsified Structure – The Concept of Fast vs Slow Lipids

Dr. Marie-Caroline Michalski is the Research Director of INRA and leader of team 4 of the CarMeN laboratory in Lyon. Her research interests revolve around the impact of food lipid structure and organization on their health effects. After training in food industry engineering and earning her PhD degree (ENSAIA, Nancy, 1992-1998), she developed research programs on the structure and properties of milk fat and milk fat globules at the Milk and Egg Science and Technology Laboratory of INRA in Rennes (199-2005). Since 2004, she has developed in the CarMeN laboratory a new research theme on the impact of the structure of lipids on their intestinal absorption and metabolic effects, in close collaboration with CRNH Rhône-Alpes. Her work has brought to light that in humans, lipid digestion is accompanied by the absorption of endotoxins present in the gut microbiota, this phenomena being increased following a period of over-nourishment. The results on the use of different fatty acids by the body, depending on the ingestion of fat in a spreadable or emulsified form have led to the new concept of “rapid vs slow lipids” in the evaluation of metabolic risks linked to the development of obesity. She is the lead investigator on various projects supported by public agencies and by industrial partners such as the ANR VALOBAB project, aimed at promoting polar lipids from buttermilk with potential functional and metabolic benefits. MC Michalski was recently decorated Knight of the Order of Agricultural Merit, awarded by the French Agricultural Ministry for her 15 years contribution do scientific research in the fields of food sciences and nutrition.

 

SESSION 2 – Healthy Aging and Inflammation Infamm’aging

Philip_CALDER

Dr. Philip Calder
• Professor of Nutritional Immunology, University of Southampton, United Kingdom

Dr. Philip Calder is Professor of Nutritional Immunology within the Human Development and Health Academic Unit of the Faculty of Medicine at the University of Southampton. He is interested in the interaction of nutrients, especially fatty acids, with immunity and inflammation. Dr. Calder has received several awards for his work, has over 400 research publications (excluding abstracts) and is listed on isiHighlyCited. Professor Calder has served on various committees and expert panels. He has recently retired as Editor-in-Chief of the British Journal of Nutrition and is an Associate Editor of Clinical Science and of Lipids. He is a member of the several other Editorial Boards.

Philip M. Sherman, MD, FRCPC
• Scientific Director 

Professor of Paediatrics, Microbiology, & Dentistry at the Hospital for Sick Children, University of Toronto where he has been on faculty since 1984. Phil completed medical school at the University of Calgary in 1977 and training in pediatrics at the University of California, San Francisco (1977-1980). Training in gastroenterology and research was completed at the Hospital for Sick Children in Toronto, and the Walter Reed Army Institute of Research in Washington, DC (1980-1984).

Phil is a Past-President of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and a Past-President of the Canadian Association of Gastroenterology. He is the recipient of a Canada Research Chair (tier 1) in Gastrointestinal Disease (2001-2015). His research program is funded by support currently provided by the Crohn’s and Colitis Foundation of Canada and the Canadian Institutes of Health Research (CIHR). His research interests focus on epithelial cell signal transduction responses to pathogenic, commensal, and probiotic bacteria.

SESSION 3 – Digestive Health, the Role of Microbiota

Patrice Cani

Dr. Patrice Cani
• Researcher, Université catholique de Louvain, Belgium

Dr. Patrice D. Cani is a researcher at the Belgian Fund for Scientific Research and group leader in the Metabolism and Nutrition lab at the Louvain Drug Research Institute (UCL) in Brussels, Belgium. He is co-director of the European Associated Laboratory “NeuroMicrobiota” (INSERM, Toulouse, France/UCL, Brussels, Belgium). Dr. Cani’s main research interests are the investigation of interactions between the gut microbiota, host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type-2 diabetes and metabolic inflammation. He is author and co-author of more than 125 scientific research publications and a member of several international associations.

Dr. Denis Roy
Professor, INAF, Université Laval, Canada

Dr. Denis Roy obtained a BSc and an MSc in Microbiology and a PhD in Food Science and Technology at Université Laval. He was chief scientist from 1986 to 2003 for the Dairy Section of the Food Research and Development Centre of Agriculture and Agri-Food Canada in St-Hyacinthe, Quebec. He later joined the Dairy Research Centre (STELA) and became Industrial Research Chair in Cheese Technology and Typicity. Dr. Roy is currently Professor at the Department of Food Sciences and Nutrition at Université Laval and an INAF member. He also holds a Canada Research Chair in Lactic Cultures Biotechnology for Dairy and Probiotic Industries. Dr. Roy is a member of the Executive Committee of the Association for Health Ingredients in Food (AISA).

Session 4 – Brain Function and Cognitive Health

Lucile CapuronDr. Lucile CAPURON
 Researcher, Université de Bordeaux, France

Dre Lucile Capuron is research director and co-director of the group Psychoneuroimmunology and Nutrition: Experimental and Clinical Approaches, inside the Integrated Nutrition and Neurobiology lab at the INRA at l’Université de Bordeaux. The general aim of this laboratory’s research is to est explain physiopathologic mechanisms involved in the development of mood and cognition disorders linked to consumption of food from the Western type diet. This diet is characterized by a high level of saturated fatty acids and a deficit in omega 3 polyunsaturated fatty acids.

Dr. Frédéric Calon  
• Professor, INAF, Université Laval, Canada

Frédéric Calon is a professor at the School of Pharmacy at Laval University as well as a member of INAF and Quebec City’s university hospital system. His research focuses on neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and essential tremor. His previous research confirmed the positive effects of an Omega-3 fatty acid on mice presenting symptoms of AD, PD, or stroke. His group demonstrated the effects of dietary Omega-3 on the electrophysiological health of neurons and neuroinflammation. Dr. Calon has co-authored 100 peer-reviewed publications, 154 conference abstracts, and numerous articles in professional journals or by invitation.

SESSION 5 – Muscle and Bone Health

Dr. Claudia Gagnon
• Professor, INAF, Université Laval, Canada

Dr. Claudia Gagnon, MD, specializes in internal medicine, endocrinology and metabolism. She completed additional training on phosphate calcium metabolism and bone diseases at the University of Melbourne in Australia. Since 2011, she has served as assistant professor at the Faculty of Medicine of Université Laval. She shares her time between research and practising specialized endocrinology medicine at the University Hospital Centre in Quebec City. Dr. Gagnon has expertise in research on vitamin D, more specifically on its potential role in preventing and treating type-2 diabetes. She also has research and clinical expertise on bone diseases and phosphate-calcium metabolism disorders. She is very interested in risk of fractures following bariatric surgery.

Robin M. Daly

Dr. Robin M. Daly
• Professor, Deakin University, Australia

Professor Robin Daly has over 20 years of experience in conducting human clinical, public health and translational intervention trials to evaluate the role of exercise and nutrition for preventing and managing common chronic diseases such as osteoporosis, sarcopenia, falls, type 2 diabetes and prostate cancer as well as cognitive related disorders. He is also interested in health issues related to vitamin D deficiency (and treatment), dietary protein and chronic low-grade systemic inflammation, and the translation of evidence-based research into practice. He has been an active contributor nationally and internationally to clinical guidelines in the area of exercise, calcium and vitamin D for osteoporosis and fracture prevention. He is a fellow of Sports Medicine Australia, a member of the Medical and Scientific Advisory Committee of Osteoporosis Australia and a council member of the Australian and New Zealand Bone and Mineral Society. He is also the founder of the ‘Osteo-cise: Strong Bones for Life’ community-based osteoporosis prevention exercise program.

Session 6 – Health attributes of nordic natural resources

Yves Desjardins

Dr. Yves Desjardins
• Professor, INAF, Université Laval, Canada

Dr. Yves Desjardins obtained a Ph.D. in Plant Science at Université Laval. Since 2002, he is full professor at Université Laval and is responsible for the plant products interest group of INAF. After have being head of Université Laval Centre for Horticulture Research at the beginning of the years 2000, he became involved in the field of health effects of fruits and vegetables and was instrumental in the creation of the Institute of Nutrition and Functional Food (INAF). As academic director of thiIHC2014s institute, he organized the first International Symposium on Health effects of Fruits and Vegetables (FAVHEALTH) in 2005 in Quebec City. Dr. Desjardins is now interested in the genetics of polyphenols production and accumulation in small fruits, their effect on diabetes, neurodegeneration and gut microbiota. His recent research focuses on the characterization and extraction of polyphenols and particularly proanthocyanidins found in blueberries and cranberries and their effects on cardiovascular diseases, metabolic syndrome, diabetes and other chronic diseases. He has led many networks of excellence at the national level and is active in many international networks in France, Belgium, and Italy.

Pierre Ayotte
• Responsable de la division recherche – Institut national de santé publique

Biography : Coming soon

BÉNÉFIQ IS …
The International Rendez-vous on Health Ingredients that was held from October 4 to 6, 2016, at the Quebec City Convention Centre. BÉNÉFIQ is a unique, world-class event combining science with business. With a large socioeconomic scope, the event is a motor for innovation in its areas of excellence.

MAIN PARTNER

Ville de Québec

FINANCIAL PARTNERS

Québec International Aliments Santé Accord Capitale-NationaleRSTMTransformActionAgroboreal

 

Pin It on Pinterest

Share This